Innovative drugs: From basic research to production
- Authors: Myasoedov N.F.1
-
Affiliations:
- Institute of Molecular Genetics
- Issue: Vol 86, No 3 (2016)
- Pages: 151-157
- Section: Scientific Session of the General Meeting of the Russian Academy of Sciences
- URL: https://journals.rcsi.science/1019-3316/article/view/178684
- DOI: https://doi.org/10.1134/S1019331616030084
- ID: 178684
Cite item
Abstract
The results of studies of the molecular action mechanism of the peptides Semax and Selank—simple glyprolines that are used to prepare peptide-based drugs—are presented. A concept of creating an amino acid sequence of peptides is given; their interaction with receptor systems of the cell and their influence on the cell’s transcriptome, which forms the cell-mediated response, are considered. On the basis of the findings, pharmaceutical compositions of peptide drugs have been developed and their production and introduction into clinical practice have been organized.
Keywords
About the authors
N. F. Myasoedov
Institute of Molecular Genetics
Author for correspondence.
Email: nfm@img.ras.ru
Russian Federation, Moscow